# CVD Equipment Corp: financial statements, quarterly

CVV · Nasdaq · CIK 766792 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cvv.md) · [Financials](/companies/cvv/financials.md) · [Filings](/companies/cvv/filings.md) · [Insiders](/companies/cvv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cvv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6.2](/filings/0001493152-24-045104.md) | [4.1 d](/filings/0001493152-25-010917.md) | [4.9](/filings/0001641172-25-009937.md) | [6.3](/filings/0001641172-25-023180.md) | [8.2](/filings/0001493152-25-021504.md) | [7.4 d](/filings/0001493152-26-013567.md) | [6.3](/filings/0001493152-26-023044.md) | [3.4](/filings/0001493152-26-037328.md) | [7.4](/filings/0001493152-25-021504.md) | [5.0 d](/filings/0001493152-26-013567.md) | [1.8](/filings/0001493152-26-023044.md) | [2.0](/filings/0001493152-26-037328.md) |
| Cost of revenue | $m | [4.6](/filings/0001493152-24-045104.md) | [4.5 d](/filings/0001493152-25-010917.md) | [4.1](/filings/0001641172-25-009937.md) | [4.8](/filings/0001641172-25-023180.md) | [6.4](/filings/0001493152-25-021504.md) | [5.5 d](/filings/0001493152-26-013567.md) | [4.6](/filings/0001493152-26-023044.md) | [2.9](/filings/0001493152-26-037328.md) | [5.0](/filings/0001493152-25-021504.md) | [3.9 d](/filings/0001493152-26-013567.md) | [1.7](/filings/0001493152-26-023044.md) | [1.6](/filings/0001493152-26-037328.md) |
| Gross profit | $m | [1.6](/filings/0001493152-24-045104.md) | [(0.3) d](/filings/0001493152-25-010917.md) | [0.8](/filings/0001641172-25-009937.md) | [1.5](/filings/0001641172-25-023180.md) | [1.8](/filings/0001493152-25-021504.md) | [2.0 d](/filings/0001493152-26-013567.md) | [1.7](/filings/0001493152-26-023044.md) | [0.5](/filings/0001493152-26-037328.md) | [2.4](/filings/0001493152-25-021504.md) | [1.1 d](/filings/0001493152-26-013567.md) | [0.1](/filings/0001493152-26-023044.md) | [0.3](/filings/0001493152-26-037328.md) |
| Research and development | $m | [0.7](/filings/0001493152-24-045104.md) | [0.7 d](/filings/0001493152-25-010917.md) | [0.7](/filings/0001641172-25-009937.md) | [0.7](/filings/0001641172-25-023180.md) | [0.6](/filings/0001493152-25-021504.md) | [0.6 d](/filings/0001493152-26-013567.md) | [0.7](/filings/0001493152-26-023044.md) | [0.6](/filings/0001493152-26-037328.md) | [0.6](/filings/0001493152-25-021504.md) | [0.7 d](/filings/0001493152-26-013567.md) | [0.7](/filings/0001493152-26-023044.md) | [0.7](/filings/0001493152-26-037328.md) |
| Operating income | $m | [(1.0)](/filings/0001493152-24-045104.md) | [(2.5) d](/filings/0001493152-25-010917.md) | [(1.6)](/filings/0001641172-25-009937.md) | [(0.9)](/filings/0001641172-25-023180.md) | [0.1](/filings/0001493152-25-021504.md) | [0.0 d](/filings/0001493152-26-013567.md) | [(0.3)](/filings/0001493152-26-023044.md) | [(1.4)](/filings/0001493152-26-037328.md) | [0.3](/filings/0001493152-25-021504.md) | [(1.3) d](/filings/0001493152-26-013567.md) | [(1.8)](/filings/0001493152-26-023044.md) | [(1.6)](/filings/0001493152-26-037328.md) |
| Interest expense | $m | [0.0](/filings/0001493152-23-041031.md) | [0.0 d](/filings/0001493152-24-011730.md) | [0.0](/filings/0001493152-24-018873.md) | [0.0](/filings/0001641172-25-023180.md) | [0.0](/filings/0001493152-25-021504.md) | [0.0 d](/filings/0001493152-26-013567.md) | [0.0](/filings/0001493152-26-023044.md) | [0.0](/filings/0001493152-26-037328.md) | [0.0](/filings/0001493152-25-021504.md) | [0.0 d](/filings/0001493152-26-013567.md) | [0.0](/filings/0001493152-26-023044.md) | [0.0 d](/filings/0001493152-26-037328.md) |
| Income tax | $m | [0.0 d](/filings/0001493152-24-045104.md) | [(0.0) d](/filings/0001493152-25-010917.md) | not reported | not reported | [0.0](/filings/0001493152-25-021504.md) | [0.0 d](/filings/0001493152-26-013567.md) | [0.0](/filings/0001493152-26-023044.md) | [0.0 d](/filings/0001493152-26-037328.md) | [0.0 d](/filings/0001493152-25-021504.md) | [(0.0) d](/filings/0001493152-26-013567.md) | not reported | not reported |
| Net income | $m | [(0.8)](/filings/0001493152-24-045104.md) | [(2.3) d](/filings/0001493152-25-010917.md) | [(1.5)](/filings/0001641172-25-009937.md) | [(0.8)](/filings/0001641172-25-023180.md) | [0.2](/filings/0001493152-25-021504.md) | [0.1 d](/filings/0001493152-26-013567.md) | [0.4](/filings/0001493152-26-023044.md) | [(1.1)](/filings/0001493152-26-037328.md) | [0.4](/filings/0001493152-25-021504.md) | [(1.3) d](/filings/0001493152-26-013567.md) | [(1.7)](/filings/0001493152-26-023044.md) | [12.6](/filings/0001493152-26-037328.md) |
| Diluted EPS | $ per share | [(0.11)](/filings/0001493152-24-045104.md) | not reported | [(0.22)](/filings/0001641172-25-009937.md) | [(0.11)](/filings/0001641172-25-023180.md) | [0.03](/filings/0001493152-25-021504.md) | not reported | [0.05](/filings/0001493152-26-023044.md) | [(0.15)](/filings/0001493152-26-037328.md) | [0.06](/filings/0001493152-25-021504.md) | not reported | [(0.24)](/filings/0001493152-26-023044.md) | [1.81](/filings/0001493152-26-037328.md) |
| Basic EPS | $ per share | [(0.11)](/filings/0001493152-24-045104.md) | not reported | [(0.22)](/filings/0001641172-25-009937.md) | [(0.11)](/filings/0001641172-25-023180.md) | [0.03](/filings/0001493152-25-021504.md) | not reported | [0.05](/filings/0001493152-26-023044.md) | [(0.15)](/filings/0001493152-26-037328.md) | [0.06](/filings/0001493152-25-021504.md) | not reported | [(0.24)](/filings/0001493152-26-023044.md) | [1.81](/filings/0001493152-26-037328.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.3](/filings/0001493152-23-041031.md) | [14.0](/filings/0001493152-25-010917.md) | [11.9](/filings/0001493152-24-018873.md) | [10.0](/filings/0001493152-24-031585.md) | [10.0](/filings/0001493152-24-045104.md) | [12.6](/filings/0001493152-26-013567.md) | [10.2](/filings/0001641172-25-009937.md) | [7.0](/filings/0001641172-25-023180.md) | [8.4](/filings/0001493152-25-021504.md) | [8.7](/filings/0001493152-26-037328.md) | [8.2](/filings/0001493152-26-023044.md) | [23.5](/filings/0001493152-26-037328.md) |
| Current assets | $m | [24.9](/filings/0001493152-23-041031.md) | [22.8](/filings/0001493152-25-010917.md) | [23.3](/filings/0001493152-24-018873.md) | [21.8](/filings/0001493152-24-031585.md) | [19.9](/filings/0001493152-24-045104.md) | [20.0](/filings/0001493152-26-013567.md) | [19.5](/filings/0001641172-25-009937.md) | [18.5](/filings/0001641172-25-023180.md) | [18.5](/filings/0001493152-25-021504.md) | [16.9](/filings/0001493152-26-037328.md) | [15.7](/filings/0001493152-26-023044.md) | [28.1](/filings/0001493152-26-037328.md) |
| Total assets | $m | [37.2](/filings/0001493152-24-045104.md) | [35.0](/filings/0001493152-25-010917.md) | [35.4](/filings/0001641172-25-009937.md) | [33.8](/filings/0001493152-24-031585.md) | [31.8](/filings/0001493152-24-045104.md) | [31.7](/filings/0001493152-26-013567.md) | [31.1](/filings/0001641172-25-009937.md) | [29.9](/filings/0001641172-25-023180.md) | [29.8](/filings/0001493152-25-021504.md) | [27.5](/filings/0001493152-26-037328.md) | [26.2](/filings/0001493152-26-023044.md) | [38.5](/filings/0001493152-26-037328.md) |
| Current liabilities | $m | [8.7](/filings/0001493152-23-041031.md) | [8.6](/filings/0001493152-25-010917.md) | [10.2](/filings/0001493152-24-018873.md) | [9.1](/filings/0001493152-24-031585.md) | [6.7](/filings/0001493152-24-045104.md) | [6.1](/filings/0001493152-26-013567.md) | [4.9](/filings/0001641172-25-009937.md) | [4.6](/filings/0001641172-25-023180.md) | [3.9](/filings/0001493152-25-021504.md) | [2.8](/filings/0001493152-26-037328.md) | [2.9](/filings/0001493152-26-023044.md) | [2.4](/filings/0001493152-26-037328.md) |
| Total liabilities | $m | [9.0](/filings/0001493152-23-041031.md) | [8.8](/filings/0001493152-25-010917.md) | [10.4](/filings/0001493152-24-018873.md) | [9.3](/filings/0001493152-24-031585.md) | [6.9](/filings/0001493152-24-045104.md) | [6.3](/filings/0001493152-26-013567.md) | [5.1](/filings/0001641172-25-009937.md) | [4.8](/filings/0001641172-25-023180.md) | [4.0](/filings/0001493152-25-021504.md) | [2.8](/filings/0001493152-26-037328.md) | [2.9](/filings/0001493152-26-023044.md) | [2.5](/filings/0001493152-26-037328.md) |
| Long-term debt | $m | [0.3](/filings/0001493152-23-041031.md) | [0.3](/filings/0001493152-25-010917.md) | [0.2](/filings/0001493152-24-018873.md) | [0.2](/filings/0001493152-24-031585.md) | [0.2](/filings/0001493152-24-045104.md) | [0.2](/filings/0001493152-26-013567.md) | [0.2](/filings/0001641172-25-009937.md) | [0.1](/filings/0001641172-25-023180.md) | [0.1](/filings/0001493152-25-021504.md) | not reported | not reported | not reported |
| Current portion of debt | $m | [0.1](/filings/0001493152-23-041031.md) | [0.1](/filings/0001493152-25-010917.md) | [0.1](/filings/0001493152-24-018873.md) | [0.1](/filings/0001493152-24-031585.md) | [0.1](/filings/0001493152-24-045104.md) | [0.1](/filings/0001493152-26-013567.md) | [0.1](/filings/0001641172-25-009937.md) | [0.1](/filings/0001641172-25-023180.md) | [0.1](/filings/0001493152-25-021504.md) | [0.2](/filings/0001493152-26-037328.md) | not reported | not reported |
| Shareholders' equity | $m | [28.2](/filings/0001493152-24-045104.md) | [26.2](/filings/0001493152-26-013567.md) | [25.0](/filings/0001641172-25-023180.md) | [24.5](/filings/0001493152-25-021504.md) | [25.0](/filings/0001493152-25-021504.md) | [25.4](/filings/0001493152-26-037328.md) | [26.0](/filings/0001493152-26-037328.md) | [25.2](/filings/0001493152-26-037328.md) | [25.8](/filings/0001493152-25-021504.md) | [24.7](/filings/0001493152-26-037328.md) | [23.3](/filings/0001493152-26-037328.md) | [36.0](/filings/0001493152-26-037328.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [757 d](/filings/0001493152-24-045104.md) | [(130) d](/filings/0001493152-25-010917.md) | [(2,043)](/filings/0001641172-25-009937.md) | [(1,729) d](/filings/0001641172-25-023180.md) | [32.0 d](/filings/0001493152-25-021504.md) | [2,251 d](/filings/0001493152-26-013567.md) | [(2,262)](/filings/0001493152-26-023044.md) | [(3,170) d](/filings/0001493152-26-037328.md) | [1,357 d](/filings/0001493152-25-021504.md) | [397 d](/filings/0001493152-26-013567.md) | [(852)](/filings/0001493152-26-023044.md) | [(425) d](/filings/0001493152-26-037328.md) |
| Capital expenditure | $k | [83.0 d](/filings/0001493152-24-045104.md) | [110 d](/filings/0001493152-25-010917.md) | [70.0](/filings/0001641172-25-009937.md) | [112 d](/filings/0001641172-25-023180.md) | [37.0 d](/filings/0001493152-25-021504.md) | [(113) d](/filings/0001493152-26-013567.md) | [45.0](/filings/0001493152-26-023044.md) | [4.0 d](/filings/0001493152-26-037328.md) | [0.0 d](/filings/0001493152-25-021504.md) | [(1.0) d](/filings/0001493152-26-013567.md) | [13.0](/filings/0001493152-26-023044.md) | [1.0 d](/filings/0001493152-26-037328.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,741](/filings/0001493152-23-041031.md) | [6,773](/filings/0001493152-24-018873.md) | [6,779](/filings/0001493152-24-031585.md) | [6,789](/filings/0001493152-24-045104.md) | [6,809](/filings/0001641172-25-009937.md) | [6,817](/filings/0001641172-25-023180.md) | [6,835](/filings/0001493152-25-021504.md) | [6,868](/filings/0001493152-26-023044.md) | [6,868](/filings/0001493152-26-037328.md) | [6,884](/filings/0001493152-25-021504.md) | [6,937](/filings/0001493152-26-023044.md) | [6,927](/filings/0001493152-26-037328.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,951,203 at 2026-08-11, from the cover of the [10-Q filed 2026-08-12](/filings/0001493152-26-037328.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.